Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse

Methamphetamine (METH) substance abuse disorders have major impact on society, yet no medications have proven successful at preventing METH relapse or cravings. Anti-METH monoclonal antibodies can reduce METH brain concentrations; however, this therapy has limitations, including the need for repeate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Hay, Charles E., Gonzalez, Guillermo A., Ewing, Laura E., Reichard, E. Elizabeth, Hambuchen, Michael D., Nanaware-Kharade, Nisha, Alam, Sinthia, Bolden, Chris T., Owens, S. Michael, Margaritis, Paris, Peterson, Eric C.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6025879/
https://ncbi.nlm.nih.gov/pubmed/29958300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0200060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados